MetaCap

Assembly Biosciences (ASMB) vs Shattuck Labs (STTK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Shattuck Labs (STTK) has outperformed Assembly Biosciences (ASMB) over the past year, gaining 119.7% versus a loss of 42.4%. Over five years, ASMB leads with a -21.3% price change compared with -52.0% for STTK. Assembly Biosciences is the larger company by market cap ($454.4 million vs $454.2 million), about 1.0 times the size.

Assembly Biosciences converts more of its revenue into profit, with a net margin of -8.5% versus -4880.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASMB-42.36%STTK+119.70%
+314%+124%-67%
Nov 21, 20251 yearNov 20, 2026
ASMB-19.60%STTK-52.55%
+46%-26%-99%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASMB versus STTK key metrics
MetricASMBSTTK
Share price$22.19$4.46
Market cap$454.39M$454.22M
1-day change-1.38%-1.98%
YTD return-34.75%+22.19%
1-year return-42.36%+119.70%
5-year return-21.31%-51.99%
P/E ratio (TTM)29.59—
EPS (TTM)$0.75$-0.47
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$72.30M$1.00M
Revenue growth (YoY)+153.52%-82.52%
Net income (latest FY)$-6.12M$-48.81M
Operating margin-16.76%-5150.80%
Net margin-8.47%-4880.90%
52-week high$39.65$8.33
52-week low$19.20$1.93
Distance from 52-week high-44.04%-46.46%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+130.73%+245.29%
Average volume309.38K1.20M
Shares outstanding20.48M101.84M
Employees7340
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • STTK has outperformed ASMB by 162.1 percentage points over the past year.
  • Assembly Biosciences is more profitable, keeping -8.5 cents of every revenue dollar as net income versus -4880.9 cents for Shattuck Labs.
  • Assembly Biosciences grew revenue faster in its latest fiscal year (+153.52% vs -82.52%).

About Assembly Biosciences

ASMB stock →

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection.

Health Care · Biotechnology: Pharmaceutical Preparations · 73 employees

About Shattuck Labs

STTK stock →

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study.

Health Care · Biotechnology: Pharmaceutical Preparations · 40 employees

ASMB vs STTK FAQ

Which is bigger, Assembly Biosciences or Shattuck Labs?

Assembly Biosciences (ASMB) is larger, with a market capitalization of $454.39M compared with $454.22M for Shattuck Labs (STTK).

Which stock has performed better over the past year, ASMB or STTK?

STTK returned +119.70% over the past 12 months, compared with -42.36% for ASMB (price return, excluding dividends). Past performance does not predict future results.

Are Assembly Biosciences and Shattuck Labs in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons